N-sulphation of desipramine in the rat brain

References

• ANDERSON, R-J, 1992, Rat brain phenol sulfotransferase: thermal stability properties, substrate correlation and inhibitor effects. Neuroendocrinolngy, 11, 181–190.
   Google Scholar
• ASBERG, M., CROXUOLM, B., SJOQVIST, F., and TUCK, D., 1971, Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, 3, 331–334.
   PubMed Web of Science ®Google Scholar
• BICKLE, M. H., and B.AGGIOLINI.M., 1966, The metabolism of imipramine and its metabolites by rat liver microsomes. Biochemical Pharmacology, 15, 1155–1169.
   Google Scholar
• BIEGON.A., 1990, Characterization and localization of binding sites for tricyclic antidepressants in rat and human brain. In Antidepressants: Thirty Years On, edited by B. Leonard and P. Spencer (London: CNS), pp. 46–53.
   Google Scholar
• BIEGON, A., and SAMUEL D., 1979, The in viro distribution of an antidepressant drug (DMI) in male and female rats. Psychopharmacology, 65, 259–263.
   Google Scholar
• BRADFORD, Al. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.
   PubMedGoogle Scholar
• BRZEZNICKA, K. A., HAZI-XTOX, G. A., and KLAASSEN, C. D., 1987, Comparison of adenosine 3'-phosphate 5'-phosphosulfate concentrations in tissues from different laboratory animals. Drug Metabolism and Disposition, 15, 133–135.
   Google Scholar
• CHRISTIANSEN, J., GRAM, L. F„ KOFOD, B.,and RAFAELSEN, O. J., 1967, Imipramine metabolism in man. A study of urinary metabolites after administration of radioactive imipramine. Psychopharmaco-logia, 11,255–264.
   Google Scholar
• CRAMMER, J. L.,and ROLFE, B., 1970, Metabolism of14C-imipramine. III. Conversion by rat tissues. Psychopharmacologia, 18, 26–37.
   Google Scholar
• CRAMMER, J. L., S COT T,B ., and ROLFE, B., 1969, Metabolism of '4C -imipramine. II. Urinary metabolites in man. Psychopharmacologia, 15, 207–225.
   Google Scholar
• DAHL, M.-L., and BERTILS SOX, L., 1993, Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics, 3, 61–70.
   PubMedGoogle Scholar
• DINGELL, J. V., SULSER, F„ and GILLETTE, J. R., 1964, Species differences in the metabolism of imipramine and desmethylimipramine (DMI). Journal of Pharmacology and Experimental Therapeutics, 143, 14–22.
   Google Scholar
• FOLDES, A., and MEEK, J. L., 1973, Rat brain phenolsulfotransferase—partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
   PubMed Web of Science ®Google Scholar
• FORBES-BAMFORTH, K. J., and Collal TRIE, M. W. H., 1994, Identification of a new adult human liver sulfotransferase with specificity for endogenous and xenobiotic estrogens. Biochemical and Biophysical Research Communications, 198, 707–711.
   Google Scholar
• GILLETTE, J. R., DIXOELL, J. V., SILSER, F., KUXTZMAX, R., and BRODIE, B. B., 1961, Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil). Experientia, 17, 417–418.
   PubMedGoogle Scholar
• GLOWLXSKI, J., and I VERSEN, L. L., 1966, Regional studies of catecholamines in the rat brain—I. The disposition of ['llJnorepinephrine, [Tl]dopamine and [ H]dopa in various regions of the brain. Journal of Neurochemistry, 13, 655–669.
   PubMedGoogle Scholar
• GRAM, L. F., 1974, Metabolism of tricyclic antidepressants. Danish Medical Bulletin, 21, 218–231.
   PubMed Web of Science ®Google Scholar
• GRAM, L. F., 1977, Factors influencing the metabolism of tricyclic antidepressants. Danish Medical Bulletin, 24, 81–89.
   PubMedGoogle Scholar
• GROSS-ISSEROFF, R, ISRAELI, M., and BIEGOX, A., 1988, Autoradiographic analysis of [' H]desmethyhmipramine binding in the human brain postmortem. Brain Research, 456,120-126. HALE, A. S., SANDLER, M., HANNAH, P., and BRIDGES, P. K., 1989, Tyramine conjugation test for prediction of treatment response in depressed patients. Lancet, 1, 234–236.
   Google Scholar
• HANSSON, T., VOX BAIIR, C, MARKLUXD, M., SVEXSSOX, J.-0., INGELMAX-SUNDBERG, M., and LUXDSTROM, J., 1992, Different regiospecificity in the hydroxylation of the antidepressant desmethylimipramine between rat brain and liver. Pharmacology and Toxicology, 71, 416–419.
   Google Scholar
• HERNANDEZ, J. S., BOWERS, S. P., and WKINSHILI3OUM, R. M., 1991, Human liver arylamine iV-sulfotransferase activity. Thermostable phenol sulfotransferase catalyzes the A^-sulfation of 2-naphthylamine. Drug Metabolism and Disposition, 19, 1071–1079.
   Google Scholar
• HRDINA, P. D., and Di RAS, T. C, 1981, Brain distribution and kinetics of desipramine in the rat. Canadian Journal of Physiology and Pharmacology, 59, 163–167.
   PubMed Web of Science ®Google Scholar
• IWASAKI, K., SHIRAGA, T., NoDA, K., TADA, K., and NoGlciU, H., 1986, A/-sulphoconjugation of alicyclic, alkyl- and aryl-amines in vivo and in vitro. Xenobiotica, 16, 651–659.
   PubMed Web of Science ®Google Scholar
• IWASAKI, K... SHIRAGA, T., TAKESHITA, K., KATASHIMA, M., XAGASE, K., TADA, K., N'ODA, K., and Noc;ucHI, H., 1993, Perinatal development of amine, alcohol and phenol sulfoconjugations in the rat. Research Communications in Chemical Pathology and Pharmacology, 81, 183–190.
   Google Scholar
• JAVAID, J. L, PERES-, J. M-, and DAVIS, J. M., 1979, Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain. Life Sciences, 24, 21–28. KHOO, B. Y., SIT, K. H., and WONG, K. P., 1988, Does PAPS generation determine the overall sulfate conjugation in human platelets? Life Sciences, 42, 2389–2395.
   Google Scholar
• KOCH-WKSKR, J., and HoLL1STER, L. E., 1978, Tricyclic antidepressants. New England Journal of Medicine, 299, 1106–1109.
   Google Scholar
• LEHMAN, J. P., FEN'SELAU, C, and DEPAULO, J. R., 1983, Quaternary ammonium-linked glucuronides of amitnptyline, imipramine, and chlorpromazine. Drug Metabolism and Disposition, 11, 221–225.
   Google Scholar
• LEMOISE;, A., GAUTIER, J. c, AZOUI.AY, D., KIFFEL, L.,BELLOC, C, GIENGERICH, F.P., MAUREL, P., BEAI'XE, P., and LEROUX, J. P., 1993, Major pathway of imipramine metabolism is catalyzed bycytochromes P-450 1A2 and P-450 3A4 in human liver. Molecular Pharmacology, 43, 827–832.
   Google Scholar
• LINEWEAVER RM AX, J. A., COOPER, T. B., SUCKOW, R. F., STEINBERG, H., BOREXSTEIN, M., BRENNER, R., and KANE, J. M, 1985, Tricyclic antidepressant and metabolite levels in chronic renal failure. Clinical Pharmacology and Therapeutics, 37, 301–307.
   PubMedGoogle Scholar
• LINEWEAVER, 11., and BuRK, D., 1934, The determination of enzyme dissociation constant. Journal of the American Chemical Society, 56, 658–666.
   Google Scholar
• LONDON, W. P., and STECK, T. L., 1969, Kinetics of enzyme reactions with interaction between a substrate and a (metal) modifier. Biochemistry, 8, 1767–1779.
   PubMed Web of Science ®Google Scholar
• LUO,H., HAWKS, E. M., MCKAY, G.,KORCHIXSKI, E. D.,and M1DHA, K. K., 1995, Jr -glucuronidation of aliphatic tertiary amines in human antidepressant versus antipsychotic drugs. Xenobiotica, 25, 291–301.
   PubMed Web of Science ®Google Scholar
• NARITOMI, Y., N1WA, T., SHIRAGA, T., IWASAKI, K.,and NODA, K., 1994, Isolation and characterization of an alicyclic amine AT-sulfotransferase from female rat liver. Biological and Pharmaceutical Bulletin, 17, 1008–1011.
   Google Scholar
• RAMASWAMY, S. G., and JAKOBY, W. B., 1987, Amine JV-sulfotransferase. Journal of Biological Chemistry, 262, 10039–10043.
   PubMed Web of Science ®Google Scholar
• REHAVI, M., SKOLXICK, P., BROWXSTEIN, M. J., and PAUL, S. M., 1982, High-affinity binding of CH]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites. Journal of Neurochemistry, 38, 889–895.
   PubMedGoogle Scholar
• REIN, G., GLOVER, V., and SANDLER, M., 1982, Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol. Biochemical Pharmacology, 31, 1893–1897.
   PubMed Web of Science ®Google Scholar
• ROMITI, P., GIULIANI, L., and PACIFICI, G. M., 1992, Interindividual variability in the Ar-sulphation of desipramine in human liver and platelets. British Journal of Clinical Pharmacology, 33, 17–23.
   PubMedGoogle Scholar
• SEAH, V. M. Y., and WONG, K. P., 1994, 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase. Biochemical Pharmacology, 47, 1743–1749.
   Google Scholar
• SHARP, S„ BARKER, E. V., COUGHTRIE, M. W. H., LOWEXSTEIX, P. R., and HUME, R., 1993, Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans. European Journal of Biochemistry, 211, 539–548.
   Google Scholar
• WEISHILBOL'M, R., and OTTERXESS, D., 1994, Sulfotransferase enzymes. In Conjugation-Deconjugtion Reactions in Drug Metabolism and Toxicity, edited by F. C. Kauffman (Berlin: Springer), pp.45–78.
   Google Scholar
• WHTTEMORE, R. M., PEARCE, L. B.,and ROTH, J. A., 1985, Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry, 24, 2477–2482.
   Google Scholar
• WHTTEMORE, R. M., PEARCE, L. B., and ROTH, J. A., 1986, Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain. Archives of Biochemistry and Biophysics, 249, 464–471.
   PubMedGoogle Scholar
• WILLIAMS, P. A., 1985, Enzpack, Version 2.0 (The Netherlands: Elsevier).
   Google Scholar
• WONG, K. O., and WONG, K. P., 1994a, Biosynthesis of 3'-phosphoadcnosine 5'-phosphosulfate (PAPS) in rat skin. Biochemical Pharmacology, 47, 477–483.
   PubMedGoogle Scholar
• WONG, K. O., and WONG, K. P., 1994b, In vitro biotransformation of desipramine by rat brain N-sulfotransferase. Canadian Journal of Physiology and Pharmacology, 72, (Suppl. 1), 296.
   Google Scholar